UBS Group’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $4.02K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $20.3K | Sell |
|
|||||
|
2023
Q4 | $35.4K | Sell |
|
|||||
|
2023
Q3 | $30K | Buy |
|
|||||
|
2023
Q2 | $11.8K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $82.2K | Buy |
|
|||||
|
2022
Q3 | $24K | Buy |
|
|||||
|
2022
Q2 | $7K | Sell |
|
|||||
|
2022
Q1 | $47K | Sell |
|
|||||
|
2021
Q4 | $89K | Buy |
|
|||||
|
2021
Q3 | $6K | Sell |
|
|||||
|
2021
Q2 | $17K | Sell |
|
|||||
|
2021
Q1 | $141K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $27K | Buy |
|
|||||
|
2020
Q2 | $4K | Sell |
|
|||||
|
2020
Q1 | $26K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $6K | Sell |
|
|||||
|
2019
Q2 | $37K | Buy |
|
|||||
|
2019
Q1 | $2K | Sell |
|
|||||
|
2018
Q4 | $47K | Sell |
|
|||||
|
2018
Q3 | $101K | Buy |
|
|||||
|
2018
Q2 | $35K | Buy |
|
|||||
|
2018
Q1 | $27K | Buy |
|
|||||
|
2017
Q4 | $20K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1K | Sell |
|
|||||
|
2017
Q1 | $22K | Sell |
|
|||||
|
2016
Q4 | $35K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $9K | Sell |
|
|||||
|
2015
Q4 | $54K | Buy |
|
|||||
|
2015
Q3 | $2K | Sell |
|
|||||
|
2015
Q2 | $31K | Buy |
|
|||||
|
2015
Q1 | $8K | Buy |
|